Clinical Trials Browser

Phase 2 × Recurrence × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

NCT06651853 2025-07-23

Large Fraction Radiation Therapy Combined With Lenalidomide, and Glofitamab in Refractory Relapsed DLBCL

Phase 2 Recruiting

Recurrence, Lymphoma, Large B-Cell, Diffuse